Search

Your search keyword '"Taylor, Valerie H."' showing total 573 results

Search Constraints

Start Over You searched for: Author "Taylor, Valerie H." Remove constraint Author: "Taylor, Valerie H."
573 results on '"Taylor, Valerie H."'

Search Results

3. Depression-Anxiety Coupling Strength as a predictor of relapse in major depressive disorder: A CAN-BIND wellness monitoring study report

4. Atypical Brain Aging and Its Association With Working Memory Performance in Major Depressive Disorder

6. A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study

7. Gray matter volume drives the brain age gap in schizophrenia: a SHAP study

8. Peripheral inflammatory biomarkers define biotypes of bipolar depression

11. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes

12. Atypical brain aging and its association with working memory performance in major depressive disorder

16. Reducing readmission rates for individuals discharged from acute psychiatric care in Alberta using peer and text message support: Protocol for an innovative supportive program

17. Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study

18. Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial

19. Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial

21. Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Study.

22. Patient Perceptions of Microbiome-Based Therapies as Novel Treatments for Mood Disorders: A Mixed Methods Study: Perceptions des patients sur les thérapies basées sur le microbiome pour les troubles de l'humeur : une étude à méthodes mixtes

26. Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study

29. Influence of CYP2C19 , CYP2D6 , and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study.

31. Pathways to eating in children and adolescents with obesity

32. Impact of a Web-Based Clinical Decision Support System to Assist Practitioners in Addressing Physical Activity and/or Healthy Eating for Smoking Cessation Treatment: Protocol for a Hybrid Type I Randomized Controlled Trial

33. 286. Genetic Polymorphism of Brain-Derived Neurotrophic Factor is Related to Antidepressant Efficacy and Treatment-Induced Hippocampal Plasticity in Patients With Major Depressive Disorder: CAN-BIND-1 Study

34. Influence of CYP2C19, CYP2D6, and ABCB1Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study

40. ABCB1gene variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐analysis including results from the CAN‐BIND ‐1 Study

41. A standardized workflow for long-term longitudinal actigraphy data processing: One year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study

43. The microbiome and mental health: Hope or hype?

44. Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report.

45. ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from the CAN‐BIND‐1 Study.

49. The effect of interventions targeting gut microbiota on depressive symptoms: a systematic review and meta-analysis

Catalog

Books, media, physical & digital resources